ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors. Anzu Partners led the $14M financing round with participation from Amgen Ventures and EDBI.
Fresh investment from prominent investors will propel Fazz into a new season of growth and further accelerate the future of Business Finance in Southeast Asia.
Pindrop, a global technology leader offering security, identity, and intelligence for every voice, today announced its expansion into the Asia-Pacific region, with entry into Singapore as its first move.
DataStax, the real-time data company, announced that it has secured $115 million in funding led by the Growth Equity business within Goldman Sachs, with participation from Rokos Capital and Singapore-based global investor EDBI.
Tessa Therapeutics, a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the close of a US$126 million Series A financing round.
Aspen Neuroscience, Inc., a private biotechnology company developing autologous cell therapies, including the first iPSC-derived autologous neuron replacement treatment for Parkinson’s disease, announced the close of its Series B funding round of $147.5 million.
Neuron Mobility, Canada’s fastest-growing shared e-scooter and e-bike operator, announces it has successfully raised US$43.5 million in Series B funding. This follows 19 months of significant growth and brings the company’s total funding to US$77.7 million.
Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, announces the grand opening of its new Technology Design Center in Singapore.